1,463 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Consumer Sales in China Are Still a Trouble Spot for This Dividend King. Here's What to Watch Out for Before You Buy the Stock https://www.fool.com/investing/2024/03/09/consumer-sales-in-china-are-still-a-trouble-spot-f/?source=iedfolrf0000001 Mar 09, 2024 - Hormel's business turned for the better in the fiscal first quarter of 2024, but China is still not performing as well as hoped.
Don't Leave Money on the Table — How to Find Out If You're Underpricing Your Products (and What to Do About It) https://www.entrepreneur.com/growing-a-business/are-you-underpricing-your-products-heres-how-to-find-out/468841 Mar 09, 2024 - Studies show most incorrectly priced products are priced too low. Learn to bridge the gap between actual and perceived value, identify maximum customer willingness-to-pay and adopt metric-based pricing for increased profitability.
Anthony Joshua takes out Francis Ngannou with crushing 2nd-round KO https://www.ocregister.com/2024/03/08/anthony-joshua-takes-out-francis-ngannou-with-crushing-2nd-round-ko/ Mar 08, 2024 - The former heavyweight champ dominates his matchup with the ex-UFC heavyweight champ in Saudi Arabia, flooring him in the first round and again early in the second, then apparently knocking Ngannou out cold with an unblocked right hand.
Lakers’ LeBron James sits out vs. Bucks because of ankle https://www.ocregister.com/2024/03/08/lakers-lebron-james-to-sit-out-vs-bucks-because-of-ankle/ Mar 08, 2024 - It is the ninth missed game this season for the 39-year-old future Hall of Famer, who was downgraded to out before tip-off and has been dealing with a left ankle injury for months.
Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche https://seekingalpha.com/article/4677111-wave-life-sciences-weighty-ambition-carving-out-obesity-niche?source=feed_all_articles Mar 08, 2024 - Wave enters the obesity market with INHBE clinical candidate, but faces fierce competition, financial concerns, and mixed market sentiment. Read my analysis of WVE.
Medical Properties Trust: Down, But Not Out (Rating Upgrade) https://seekingalpha.com/article/4677101-medical-properties-trust-down-but-not-out-rating-upgrade?source=feed_all_articles Mar 08, 2024 - Medical Properties Trust is undervalued but has a high dividend yield, making it an attractive investment. Find out why MPW stock is upgraded from Hold to Buy.
Zuora (ZUO) Recently Broke Out Above the 50-Day Moving Average https://www.zacks.com/stock/news/2237986/zuora-zuo-recently-broke-out-above-the-50-day-moving-average?cid=CS-ZC-FT-tale_of_the_tape|50_day_moving_average_(yseop)-2237986 Mar 08, 2024 - Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
How ACM Research (ACMR) Stock Stands Out in a Strong Industry https://www.zacks.com/stock/news/2237877/how-acm-research-acmr-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2237877 Mar 08, 2024 - ACM Research (ACMR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
How AssetMark (AMK) Stock Stands Out in a Strong Industry https://www.zacks.com/stock/news/2237883/how-assetmark-amk-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2237883 Mar 08, 2024 - AssetMark (AMK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Cigna eyes $0 out-of-pocket for Humira biosimilar this year https://seekingalpha.com/news/4077324-cigna-eyes-0-out-of-pocket-humira-biosimilar?source=feed_sector_healthcare Mar 07, 2024 - Health insurer Cigna (CI) plans to launch a biosimilar for AbbVie's (ABBV) arthritis therapy Humira with $0 out-of-pocket expenses for eligible patients. Read more here.
<<<Page 103>